Laurus Labs
Update in progressLAURUSLABS.NS (NSE)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
Laurus Labs Limited and its subsidiaries manufacture and sell medicines and active pharmaceutical ingredients (APIs) in India and abroad. It offers generics APIs and oral solid formulations across ARV, antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology and hepatitis C. The company provides biotech services for nutraceuticals, dietary supplements and cosmeceuticals, plus enzymatic solutions for industrial biotech and animal-origin-free recombinant proteins for biopharma, with pharma business support services. Incorporated in 2005, based in Hyderabad, India.
Company score
- Sentiment
- 0.39
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.32
- Governance
- 0.08
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.11
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.25
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNSE (NSI)
- LocationIndia
- CEODr. Satyanarayana Chava M.Sc., Ph.D.
- Founded2005
- Employees7,059
- Websitewww.lauruslabs.com
Identifiers
- ISININE947Q01028